Literature DB >> 17597400

Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease.

J L Perez-Calle1, I Marin-Jimenez, P Lopez-Serrano, J P Gisbert, A S Pena, C Fernandez-Rodriguez.   

Abstract

Macro-creatine-kinases are isoenzymes of creatinine-kinases (CK). They have been classified in two types: type 1 (CK bound to an immunoglobulin) and type 2 (an oligomeric mitochondrial CK). CK type 1 has been found in patients with ulcerative colitis (UC) but not in Crohn's disease (CD). However, there are no studies evaluating macro-creatinkinase prevalence in inflammatory bowel disease (IBD). We included 159 consecutive patients (72 UC, 85 CD; 2 indeterminate colitis). Creatin-kinase total activity and isoenzymes activities were determined. Twelve (16.7%) patients with UC and one of the two patients with indeterminate colitis had serum macro-creatinkinase type 1 while no CD patients displayed this macromolecule (P < 0,001). Sensitivity, specificity, positive and negative predictive value, and positive and negative likelihood ratio were calculated for ulcerative colitis versus Crohn's disease diagnosis, being 16.7, 98.9, 92.3, 59, 14.5, and 0.84% respectively. There was no correlation with age, gender, time from diagnosis, associated diseases, concomitant medication or disease activity. In conclusion our data suggests that the presence of macro-CK in IBD favors the diagnosis of ulcerative colitis. Further studies are necessary to understand the significance of this finding in a subset of patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597400     DOI: 10.1007/s10620-007-9888-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  [Macro creatine kinase type 1 as a cause of increase of CF-MB isoenzyme. Apropos of 7 cases].

Authors:  F Rosa-Jiménez; M Gassó de Campos; M V Camacho Reina; E Vázquez de Castroviejo; J J Hernández Burruezo; H Pousibet Sanfeliú
Journal:  Rev Esp Cardiol       Date:  1997-03       Impact factor: 4.753

Review 2.  [The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].

Authors:  J P Gisbert; F Gomollón; J Maté; J M Pajares
Journal:  Gastroenterol Hepatol       Date:  2003-05       Impact factor: 2.102

Review 3.  Macroenzymes: biochemical characterization, clinical significance, and laboratory detection.

Authors:  A T Remaley; P Wilding
Journal:  Clin Chem       Date:  1989-12       Impact factor: 8.327

Review 4.  Autoimmune reactivity in inflammatory bowel disease.

Authors:  D F Keren; J A Goeken
Journal:  Clin Lab Med       Date:  1997-09       Impact factor: 1.935

5.  [Determination of creatine kinase-MB in serum using inhibiting antibodies (author's transl)].

Authors:  U Würzburg; N Hennrich; H Lang; W Prellwitz; D Neumeier; M Knedel
Journal:  Klin Wochenschr       Date:  1976-04-15

6.  Enzyme-linked immunoglobulins and their clinical significance.

Authors:  T Tozawa
Journal:  Electrophoresis       Date:  1989 Aug-Sep       Impact factor: 3.535

7.  Macromolecular creatine kinase type 1: a serum marker associated with disease.

Authors:  M Laureys; J P Sion; H Slabbynck; L Steenssens; C Cobbaert; M P Derde; F K Gorus
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

8.  University of Virginia case conference. Macroamylase, macro creatine kinase, and other macroenzymes.

Authors:  T E Mifflin; D E Bruns; U Wrotnoski; R H MacMillan; R G Stallings; R A Felder; D A Herold
Journal:  Clin Chem       Date:  1985-10       Impact factor: 8.327

9.  Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data.

Authors:  K N Lee; G Csako; P Bernhardt; R J Elin
Journal:  Clin Chem       Date:  1994-07       Impact factor: 8.327

10.  Creatine kinase in serum: 2. Interference of adenylate kinase with the assay.

Authors:  G Szasz; W Gerhardt; W Gruber; E Bernt
Journal:  Clin Chem       Date:  1976-11       Impact factor: 8.327

View more
  1 in total

1.  Serum macromolecular creatine kinase type 1 as a diagnostic clue in inflammatory bowel disease?

Authors:  K Martin Hoffmann; Marlene Grillitsch; Andrea Deutschmann; Christoph Högenauer; Tatjana Stojakovic; Almuthe C Hauer
Journal:  Eur J Pediatr       Date:  2013-01-18       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.